H. Mani

发表

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation

J. Ansell, H. Mani, J. Douxfils, 2015, BioMed research international.

Main considerable factors for correct laboratory test interpretation under DOA treatment

H. Mani, E. Lindhoff‐Last, E. Lindhoff-Last, 2013, Thrombosis Journal.

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations

J. Dogné, B. Châtelain, F. Mullier, 2015, BioMed research international.

Measuring the anticoagulant effects of target specific oral anticoagulants—reasons, methods and current limitations

H. Mani, E. Lindhoff‐Last, A. Kasper, 2013, Journal of Thrombosis and Thrombolysis.

Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant

E. Herrmann, W. Pfeilschifter, H. Mani, 2014, Therapeutic drug monitoring.

Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up

H. Mani, E. Lindhoff‐Last, J. Schwonberg, 2009, Annals of Hematology.

Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease.

S. Toennes, H. Mani, E. Lindhoff‐Last, 2010, Atherosclerosis.

Assessment of clopidogrel non-response by the PFA-100® system using the new test cartridge INNOVANCE® PFA P2Y

A. Rechner, H. Mani, E. Lindhoff‐Last, 2010, Annals of Hematology.

Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin

E. Perzborn, C. Hesse, H. Mani, 2012, Thrombosis and Haemostasis.

Development and Clinical Evaluation of Two Chromogenic Substrate Methods for Monitoring Fondaparinux Sodium

H. Mani, B. Luxembourg, E. Lindhoff‐Last, 2006, Therapeutic drug monitoring.

Interpretation of coagulation test results under direct oral anticoagulants

H. Mani, 2014, International journal of laboratory hematology.

Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary

H. Mani, E. Lindhoff‐Last, J. Schwonberg, 2008, Journal of thrombosis and haemostasis : JTH.

Response to aspirin and clopidogrel monitored with different platelet function methods

H. Mani, B. Luxembourg, E. Lindhoff‐Last, 2006, Platelets.

Platelet function testing in hirudin and BAPA anticoagulated blood

H. Mani, E. Lindhoff‐Last, Mirna Hellis, 2011, Clinical chemistry and laboratory medicine.

Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements

H. Mani, B. Luxembourg, E. Lindhoff‐Last, 2005, Journal of Clinical Pathology.

Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time

C. Hesse, H. Mani, E. Lindhoff‐Last, 2011, Thrombosis and Haemostasis.

Influence of blood collection techniques on platelet function

M. Schindewolf, H. Mani, B. Luxembourg, 2004, Platelets.

Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions

C. Geisen, S. Toennes, H. Mani, 2007, Thrombosis and Haemostasis.

[Resistance to acetylsalicylic acid and clopidogrel: current status].

H. Mani, E. Lindhoff‐Last, 2006, Hamostaseologie.

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

H. Mani, E. Lindhoff‐Last, E. Lindhoff-Last, 2014, Drug design, development and therapy.

Determination of Clopidogrel Main Metabolite in Plasma: A Useful Tool for Monitoring Therapy?

S. Toennes, G. Kauert, H. Mani, 2008, Therapeutic drug monitoring.

Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions

C. Hesse, H. Mani, Gertrud Stratmann, 2012, Thrombosis and Haemostasis.

Stellenwert der Thrombozytenfunktionsdiagnostik

H. Mani, E. Lindhoff-Last, H. Mani, 2010, Der Internist.